AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
17.33
+0.04 (0.23%)
Sep 3, 2025, 4:00 PM - Market closed
PSIL Holdings Information
PSIL is an equity ETF with a total of 27 individual holdings. The top holdings are Atai Life Sciences stock at 15.04%, Mind Medicine (MindMed) at 7.62%, Neuphoria Therapeutics at 6.75%, COMPASS Pathways at 6.66%, and Cybin at 6.23%.
Total Holdings
27
Top 10 Percentage
69.47%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
14.01M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | Atai Life Sciences N.V. | 15.04% |
| 2 | MNMD | Mind Medicine (MindMed) Inc. | 7.62% |
| 3 | NEUP | Neuphoria Therapeutics Inc. | 6.75% |
| 4 | CMPS | COMPASS Pathways plc | 6.66% |
| 5 | NEO: CYBN | Cybin Inc. | 6.23% |
| 6 | ALKS | Alkermes plc | 5.91% |
| 7 | NRXP | NRx Pharmaceuticals, Inc. | 5.47% |
| 8 | GHRS | GH Research PLC | 5.37% |
| 9 | VTGN | Vistagen Therapeutics, Inc. | 5.31% |
| 10 | NBIX | Neurocrine Biosciences, Inc. | 5.10% |
| 11 | CSE: QNTM | Quantum BioPharma Ltd. | 4.88% |
| 12 | CSE: DRUG | Bright Minds Biosciences Inc. | 4.71% |
| 13 | STIM | Neuronetics, Inc. | 4.11% |
| 14 | SUPN | Supernus Pharmaceuticals, Inc. | 3.95% |
| 15 | RLMD | Relmada Therapeutics, Inc. | 3.48% |
| 16 | IXHL | Incannex Healthcare Inc. | 2.01% |
| 17 | ENVB | Enveric Biosciences, Inc. | 1.68% |
| 18 | CMND | Clearmind Medicine Inc. | 1.53% |
| 19 | KTTA | Pasithea Therapeutics Corp. | 1.35% |
| 20 | TSX: NUMI | Numinus Wellness Inc. | 1.19% |
| 21 | SILO | Silo Pharma, Inc. | 1.15% |
| 22 | TTTXX | BlackRock Treasury Trust Fund | 0.39% |
| 23 | PBM | Psyence Biomedical Ltd. | 0.10% |
| 24 | n/a | Cash | 0.00% |
| 25 | n/a | Sage Therapeutics Cvr | 0.00% |
As of Aug 29, 2025